Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TPN-672
DRUG
2 trials
Sponsors
Shanghai Mental Health Center
, Jiangsu Kanion Pharmaceutical Co., Ltd
Conditions
PHA1A
Schizophrenia
Early Phase 1
Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers
NCT03931668
Shanghai Mental Health Center
PHA1A
Start: 2019-04-17
End: 2020-12-17
Target: 62
Updated: 2019-12-23
Phase 1
Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia
NCT05192304
Jiangsu Kanion Pharmaceutical Co., Ltd
Schizophrenia
Start: 2022-02-01
End: 2024-03-01
Target: 62
Updated: 2022-01-14